Exact Sciences Stock Analysis

EXAS Stock  USD 48.41  1.42  2.85%   
EXACT Sciences is undervalued with Real Value of 59.38 and Target Price of 68.81. The main objective of EXACT Sciences stock analysis is to determine its intrinsic value, which is an estimate of what EXACT Sciences is worth, separate from its market price. There are two main types of EXACT Sciences' stock analysis: fundamental analysis and technical analysis.
The EXACT Sciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. EXACT Sciences is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday. EXACT Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

EXACT Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The book value of EXACT Sciences was currently reported as 12.71. The company recorded a loss per share of 5.53. EXACT Sciences had not issued any dividends in recent years. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people. To learn more about EXACT Sciences call Kevin Conroy at 608 284 5700 or check out https://www.exactsciences.com.

EXACT Sciences Investment Alerts

The company reported the previous year's revenue of 2.76 B. Net Loss for the year was (1.03 B) with profit before overhead, payroll, taxes, and interest of 1.97 B.
EXACT Sciences has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: Beacon Investment Advisory Services Inc. Has 220,000 Stock Holdings in Exact Sciences Corporation

EXACT Sciences Upcoming and Recent Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

EXACT Largest EPS Surprises

Earnings surprises can significantly impact EXACT Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2011-05-03
2011-03-31-0.09-0.080.0111 
2010-10-27
2010-09-30-0.07-0.08-0.0114 
2010-05-06
2010-03-31-0.05-0.06-0.0120 
View All Earnings Estimates

EXACT Sciences Environmental, Social, and Governance (ESG) Scores

EXACT Sciences' ESG score is a quantitative measure that evaluates EXACT Sciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of EXACT Sciences' operations that may have significant financial implications and affect EXACT Sciences' stock price as well as guide investors towards more socially responsible investments.

EXACT Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
T. Rowe Price Investment Management,inc.2025-03-31
2.9 M
William Blair Investment Management, Llc2025-03-31
2.2 M
Champlain Investment Partners, Llc2025-03-31
2.2 M
Morgan Stanley - Brokerage Accounts2025-03-31
1.8 M
Armistice Capital, Llc2025-03-31
1.8 M
Dimensional Fund Advisors, Inc.2025-03-31
1.6 M
Spyglass Capital Management Llc2025-03-31
1.6 M
Millennium Management Llc2025-03-31
1.5 M
Bamco Inc2025-03-31
1.5 M
Fmr Inc2025-03-31
27.7 M
Capital World Investors2025-03-31
17.8 M
Note, although EXACT Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

EXACT Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.13 B.

EXACT Profitablity

The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.12.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.40)(0.42)
Return On Capital Employed(0.20)(0.21)
Return On Assets(0.17)(0.18)
Return On Equity(0.43)(0.45)

Management Efficiency

EXACT Sciences has return on total asset (ROA) of (0.0183) % which means that it has lost $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3689) %, meaning that it created substantial loss on money invested by shareholders. EXACT Sciences' management efficiency ratios could be used to measure how well EXACT Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.42 in 2025. Return On Capital Employed is likely to drop to -0.21 in 2025. At this time, EXACT Sciences' Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.49 in 2025, whereas Return On Tangible Assets are likely to drop (0.42) in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 13.04  13.69 
Tangible Book Value Per Share(5.29)(5.02)
Enterprise Value Over EBITDA(15.85)(15.06)
Price Book Value Ratio 4.31  4.43 
Enterprise Value Multiple(15.85)(15.06)
Price Fair Value 4.31  4.43 
Enterprise Value352.5 M370.1 M
Evaluating the management effectiveness of EXACT Sciences allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The EXACT Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(0.12)
Profit Margin
(0.36)
Beta
0.953
Return On Assets
(0.02)
Return On Equity
(0.37)

Technical Drivers

As of the 24th of July, EXACT Sciences owns the Coefficient Of Variation of 934.98, market risk adjusted performance of 0.5175, and Downside Deviation of 1.93. EXACT Sciences technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm EXACT Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if EXACT Sciences is priced correctly, providing market reflects its prevailing price of 48.41 per share. Given that EXACT Sciences has jensen alpha of 0.1482, we urge you to verify EXACT Sciences's latest market performance to make sure the company can sustain itself in the future.

EXACT Sciences Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. EXACT Sciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for EXACT Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

EXACT Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EXACT Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

EXACT Sciences Outstanding Bonds

EXACT Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EXACT Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EXACT bonds can be classified according to their maturity, which is the date when EXACT Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

EXACT Sciences Predictive Daily Indicators

EXACT Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EXACT Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

EXACT Sciences Corporate Filings

17th of July 2025
Other Reports
ViewVerify
11th of July 2025
Other Reports
ViewVerify
24th of June 2025
Other Reports
ViewVerify
8K
16th of June 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13th of May 2025
Other Reports
ViewVerify
12th of May 2025
Other Reports
ViewVerify
F4
8th of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
1st of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

EXACT Sciences Forecast Models

EXACT Sciences' time-series forecasting models are one of many EXACT Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EXACT Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About EXACT Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how EXACT Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EXACT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EXACT Sciences. By using and applying EXACT Stock analysis, traders can create a robust methodology for identifying EXACT entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.38)(0.39)
Operating Profit Margin(0.38)(0.40)
Net Loss(0.37)(0.39)
Gross Profit Margin 0.70  0.76 

Current EXACT Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EXACT analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EXACT analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
68.81Strong Buy26Odds
EXACT Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most EXACT analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EXACT stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of EXACT Sciences, talking to its executives and customers, or listening to EXACT conference calls.
EXACT Analyst Advice Details

EXACT Stock Analysis Indicators

EXACT Sciences stock analysis indicators help investors evaluate how EXACT Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EXACT Sciences shares will generate the highest return on investment. By understating and applying EXACT Sciences stock analysis, traders can identify EXACT Sciences position entry and exit signals to maximize returns.
Begin Period Cash Flow609.7 M
Long Term Debt2.3 B
Common Stock Shares Outstanding184.2 M
Total Stockholder Equity2.4 B
Total Cashflows From Investing Activities-442.2 M
Tax Provision-7.3 M
Property Plant And Equipment Net810.6 M
Cash And Short Term InvestmentsB
Cash600.9 M
Accounts Payable89.6 M
Net Debt2.2 B
50 Day M A54.0958
Total Current Liabilities732.2 M
Other Operating ExpensesB
Non Current Assets Total4.4 B
Forward Price Earnings2500
Non Currrent Assets Other169.7 M
Stock Based Compensation214.9 M

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.